Serum IGF-1 concentration in diabetic retinopathy

Area of Science:

• Endocrinology
• Ophthalmology
• Metabolic Diseases

Background:

• Diabetic retinopathy (DR) is a leading cause of vision loss.
• Growth factors, including growth hormone and insulin-like growth factor 1 (IGF-1), are implicated in DR pathogenesis.
• Understanding the role of IGF-1 in diabetes complications is crucial.

Purpose of the Study:

• To investigate the association between serum IGF-1 levels and diabetic retinopathy.
• To compare IGF-1 levels in diabetic patients with varying stages of retinopathy and non-diabetic controls.
• To explore correlations between IGF-1, diabetes duration, age, and proteinuria.

Main Methods:

• Serum IGF-1 levels were measured in 371 diabetic patients and 73 non-diabetic controls.
• Patients were categorized based on the presence and stage of diabetic retinopathy.
• Statistical analyses were performed to compare IGF-1 levels and assess correlations, adjusting for relevant covariates.

Main Results:

• No significant difference in mean serum IGF-1 was found between diabetic and control groups.
• IGF-1 levels did not differ between diabetic patients with no retinopathy versus proliferative retinopathy.
• A significant difference was observed in the inactive previously proliferative group (lower IGF-1).
• Serum IGF-1 correlated with age in controls and negatively with age in diabetics.
• IGF-1 levels were significantly higher in diabetic patients with proteinuria compared to those without.

Conclusions:

• Serum IGF-1 levels do not appear to be a primary differentiator in the overall progression of diabetic retinopathy.
• Proteinuria in diabetic patients is strongly associated with elevated serum IGF-1 levels.
• Further research is warranted to elucidate the specific role of IGF-1 in the context of diabetic nephropathy and retinopathy.